This inventor holds 4 USPTO granted patents. Top assignees: American Home Products Corporation, Wyeth. Active years: 1981-2006.
Location History:
- King of Prussia, PA (US) (1981)
- Radnor, PA (US) (1982 - 2002)
- Delaware, PA (US) (2006)
Company Filing History:
Years Active: 1981-2006
Title: Alan Corbin: Innovator in Cancer Treatment
Introduction
Alan Corbin is a notable inventor based in Delaware, PA (US), recognized for his contributions to the field of cancer treatment. With a total of four patents to his name, Corbin has made significant strides in developing methods to combat estrogen receptor positive carcinoma.
Latest Patents
Among his latest patents is a method of treating estrogen receptor positive carcinoma with 17α-dihydroequilin. This invention provides a method of treating estrogen receptor positive carcinoma in a mammal in need thereof, which comprises administering an antineoplastic amount of 17α-dihydroequilin or a mammalian metabolic conjugate thereof through various routes such as orally, parenterally, transdermally, topically, rectally, intravaginally, intranasally, or intrabronchially. The compounds of this invention are particularly useful in treating estrogen receptor positive carcinomas affecting various organs, including the breast, uterus, ovary, and more.
Career Highlights
Corbin has worked with prominent companies in the pharmaceutical industry, including American Home Products Corporation and Wyeth. His experience in these organizations has contributed to his expertise in developing innovative treatments for cancer.
Collaborations
Some of his notable coworkers include Michael S. Dey and Frederick J. Bex, who have collaborated with him on various projects throughout his career.
Conclusion
Alan Corbin's work in the field of cancer treatment exemplifies the impact of innovation in medicine. His patents and collaborations highlight his commitment to improving therapeutic options for patients with estrogen receptor positive carcinoma.